Introduction

To enhance the general health and disease resistance of cultured fish, particularly during the fry stage, feeds may be supplemented with health-promoting additives, reducing the need to use chemotherapeutics. A wide variety of concepts and additives are being investigated for their ability to improve digestion and feed utilisation in the field of fish nutrition. Short-chain fatty acids (SCFAs)/organic acids (C1–C7) and/or their respective salts, commonly known as acidifiers, are potential substitutes for antibiotic growth promoters in aquafeeds that are receiving increasing attention (Ng and Koh, 2016; Lückstädt, 2008a,b). Acidifiers are a type of feed supplement that acts as conserving agents in the animal gut by reducing the pH of feed and inhibiting microbial growth (Lückstädt, 2008a). Many organic acids or SCFAs are also available in sodium, potassium, and calcium salts, with the advantages of being odourless, less corrosive, and easy to manipulate as a feed additive because of their solidity and lack of volatility (Partanen and Mroz, 1999). More recently, the use of dietary organic acids/salts as supplements in the culture of aquatic animals to improve health and limit the use of antibiotics has been the focus of much research on aquafeeds. According to several studies, some dietary acidifiers can significantly enhance the growth, feed utilisation, and immunity of fish (Hoseinifar et al., 2017; Ng and Koh, 2016). Whilst the potential for these acidifiers to act as growth promotors, immuno-stimulators, and health-status enhancers is known, fewer studies have assessed their effects on the intestinal microbiome (Ringø et al., 2015) or intestinal histology (Abdel-Mohsen et al., 2018). The intestinal microbiota has been linked to a wide range of biological processes that benefit the host including nutritional conditions and the immune system; therefore, it is undoubtedly an important factor determining the health status of fish.

European seabass (Dicentrarchus labrax, hereafter referred to as seabass) is regarded as a highly valuable marine fish and has a significant production volume in Mediterranean countries. Consequently, novel programmes to control disease outbreaks, reinforce immune competence, and enhance the viability of early fish stages are needed to achieve aquaculture sustainability and increase profitability. Nevertheless, there is currently an increasing interest in evaluating the potential of adding several feed supplements, including acidifiers, to seabass diets to enhance the growth, immunity, and efficiency of digestive and metabolic processes in fish. Among the more recent studies, the advantageous effects of sodium butyrate and sodium diformate on the growth, nutrient utilisation and basal health status of seabass fry, juveniles, and adults have been emphasised (Abdel-Mohsen et al., 2018; Wassef et al., 2017; Rimoldi et al., 2016). The organic acid sodium propionate (SP) has also been shown proven to promote growth naturally and effectively and support hygiene and feeding in aquatic organisms (da silva et al., 2016; Hosseini et al., 2011). The results of a few prior studies have revealed the beneficial effects of propionic acid/salts on immune response in Arctic charr, Salvelinus alpinus (Ringø, 1991); Nile tilapia, Oreochromis niloticus (Hassaan et al., 2014); zebra fish, Danio rerio (Safari et al., 2016), and Caspian white fish, Rutilus frisii kutum (Hoseinifar et al., 2017). However, the effects of dietary SP on seabass remain to be determined. Accordingly, the present study aims to evaluate the response of seabass fry to dietary supplementation with graded levels of SP in terms of growth performance, nutrient utilisation, carcass composition, health and immunity indicators, the gut microbiome, and intestinal histomorphology. These indicators will provide essential information on the optimal SP dosage, mainly as a biocontrol feed additive, to enforce disease resistance in seabass fry.

Material and methods

Experimental facilities

This experiment was conducted in the Fish Nutrition Laboratory, National Institute of Oceanography and Fisheries (NIOF), Alexandria. Hatchery-bred seabass fry (initial body weight (IBW) of approximately 0.5 g) was maintained in a reservoir tank and fed a control (CTRL) diet for a 2-week acclimatisation period. Thereafter, 8 groups of 150 fish were distributed among 0.5-m3 fibreglass tanks filled with filtered and UV-treated fresh seawater with a flow-through (120 l/h) system in duplicate for each treatment. The water temperature was adjusted to 22 ± 1 °C and monitored by a thermometer, and a dissolved oxygen concentration of 7–8 mg/l was maintained at a saturation level of 90–100% (YSI Professional Series Instrument, USA). The salinity was approximately 35 g/l (Portable Refractometer, Operating Instructions, GG-201/211), the pH was 8.0 ± 0.5 (pH/temperature branch metre, Italy), and the nitrogen concentrations were N2 = 0.54 ± 0.03 mg/l, NH3 = 0.73 ± 0.05 mg/l, and NH4 = 0.77 ± 0.04 mg/l (YSI EcoSense® 9300 Photometer, England). Water quality parameters were periodically checked throughout the whole experimental period to ensure that experimental fish are fulfilling the requirements of ARRIVE guidelines and in accordance with the National Institutes of Health guide for the care and use of laboratory animals (NIH Publications No. 8023, revised 1978).

All analysed water quality parameters remained within the acceptable standards for the cultivation of seabass (Vázquez and Muñoz-Cueto, 2014). The trial was conducted under a natural photoperiod regime of 14L:10D and lasted for 90 days.

Experimental diets

Four diets were formulated on an isonitrogenous (~ 52% CP), isolipidic (~ 16% L), and isoenergetic (~ 52 kJ/kg, gross energy) basis and supplemented with 1 of 4 graded levels of SP: 0.0% (CTRL diet), 0.1% (SP1 diet), 0.2% (SP2 diet), or 0.3% (SP3 diet). The ingredient composition of all diets was the same, except for SP, and fulfilled the nutritional requirements of seabass fry (NRC (National Research Council), 2011). Diets were produced in the Fish Nutrition Laboratory, NIOF, Alexandria, as crumbles (0.2-mm diameter), and the tested doses of SP (AGROCEL® Agranco Corp., USA) were selected based upon previous research with other organic salts for the same species (Wassef et al., 2017, Abdel-Mohsen et al., 2018; Rimoldi et al., 2016). Details of the diet processing method were previously described for a similar sodium butyrate experiment (Abdel-Mohsen et al., 2018). Diets were dispensed into duplicate tanks for each dietary treatment 4 times a day (8.00, 11.00, 14.00, and 17.00 h), 7 days a week, to apparent visual satiety and carefully controlled through feed intake to avoid feed wastage. The formulation and proximate composition of the experimental diets are given in Table 1.

Table 1 Formulation and proximate analyses of the experimental diets (as fed) to European seabass (Dicentrarchus labrax) fry

Sample collection

Haemato-immunological assays

At the end of the feeding period (day 91), 24 h after the last meal, 5 fish per tank were lightly anaesthetised (50 mg clove oil/l), and blood samples were immediately collected from the caudal vein by heparinised syringes and pooled for each treatment. Haematological analyses were performed following standard techniques presented in Dacie and Lewis (2006). Another set of blood samples was collected and left to coagulate at − 4 °C and then centrifuged at 3500g for 10 min. Sera were stored at − 80 °C for later use in immunological assays.

Intestinal microbiota assessments

Immediately after blood sampling, fish were euthanised, and the distal intestine (DI) was carefully aseptically excised from each fish specimen (using sterile tools) and homogenised in 10 ml of 3% sterile sodium chloride solution. These were defined as the “stock” samples. Briefly, a series of ten-time dilutions of the stock sample were followed to obtain five consecutive diluted samples labelled from 10−1 to 10−5. Microbiota community composition was determined in 1 ml from the last dilution by assays of growth on plated selective agar media. For the total count of viable bacteria (TBC), seawater agar was used (Zobell, 1946); for Vibrio spp., thiosulfate-citrate-bile salt-sucrose (TCBS) agar was used (Kobayashi et al., 1963); and for Escherichia coli, mFC agar was used (ISO (International Organization for Standardization) No. 9308/1, 1990). All plates were incubated at 30 °C for 24–48 h for enumeration, except for the mFC medium, which was incubated at 44 °C for 24 h. For cultivation of acid-fermentative bacteria, de Man, Rogosa and Sharpe (MRS) medium was used and incubated at 37 °C for 48 h under anaerobic conditions (Amiza et al., 2006). All instruments were cleaned and disinfected between individual fish specimens, and all samples were analysed in triplicate.

Intestinal histology

At termination of the trial, 3 fish from each tank were randomly selected, and their intestines were carefully excised and visually divided into 3 segments: the proximal intestine (PI), immediately following the stomach; the DI, the widened part internally from the anus; and the mid intestine (MI), the section between the PI and DI. Samples of intestinal tissues from the three portions were preserved in 4% phosphate-buffered formalin (pH of 7.4), transverse sectioned to a thickness of 5 μm (SHANDON HYPERCUT, USA), stained with haematoxylin and eosin (H&E) and mounted on slides according to standard histological techniques. The sections were processed and examined for overall features of intestinal morphology and composition by using a light microscope (Nikon Phase Contrast Dry, 0.90, Japan).

Data analyses

Growth calculations

At the start of the experiment, the fish in each tank were bulk weighed (IBW, g/fish) and counted before monitoring the growth and survival of the fish in each dietary treatment. Three fish from each tank (6 per treatment) were randomly sampled at the start and end of the trial and homogenised into a composite sample for initial and final carcass composition analyses. At the end of the trial and after 1 day of feed deprivation, all fish from each tank were lightly anaesthetised and bulk weighed, and their final body weight (FBW) was then recorded. Growth and feed utilisation indices were calculated using the following indicators: weight gain (WG, g) = FBW − IBW, specific growth rate (SGR, %/day) = 100 (ln FBW − ln IBW) / t, average daily gain (ADG, g/fish/day) = WG/t, where FBW and IBW were measured in g and “t” is the time of the experiment (days). The feeding rate (FR; %BW/day) was calculated as 100 × {crude feed intake / (IBW + FBW)/2/days}, the feed conversion ratio (FCR) was calculated as dry feed consumed (g)/fish WG (g), the protein efficiency ratio (PER) was calculated as 100 (fish WG, g) / (protein intake, g), and the protein productive value (PPV) was calculated as 100 (protein gain, g) / protein fed (g). The percentage survival of fish (S, %) was the ratio between the numbers of fish at the end to the total number of fish at the start of the experiment.

Analytical procedures

The proximate composition of diets and fish was assessed according to the standard methodology of AOAC (2015). Dry matter was determined by oven drying at 105 °C; crude protein (total N × 6.25), by using a semi-automatic Kjeldahl procedure (VELP Scientifica, UDK 126, Italy) after acid digestion; and crude lipid, gravimetrically after extraction by a chloroform/methanol (2:1 v/v) mixture (40–60 °C). The ash content was measured by burning the samples in a muffle furnace at 550 °C for 6 h. Crude fibre was analysed by the acid hydrolysis method, whereas the nitrogen-free extract was calculated as the difference. Gross energy was obtained based upon 23.6, 39.5, and 17.2 kJ/g for proteins, lipids, and carbohydrates, respectively.

Haemato-immunological analyses

Haemoglobin was determined according to Van-Kampen and Zijlstra (1961) procedure; whilst haematocrit, total number of red blood cells (RBCs, erythrocytes), and white blood cells (WBCs, leukocytes), differential leukocyte counting, and blood indices: mean cell volume (MCV), mean cell haemoglobin (MCH), and MCH concentration (MCHC) were all measured according to Dacie and Lewis (2006) techniques. All blood samples were analysed in triplicate.

The respiratory burst activity of leukocytes was assessed by Secombes (1990) method, phagocytic activity by the method in Kawahara et al. (1991), and serum lysozyme activity (LA) in Ellis (1990) with some modifications. Total myeloperoxidase content (MPO) in serum was measured according to the technique in Sahoo et al. (2005) and total immunoglobulin M (IgM) in Siwicki and Anderson (1993). All samples were analysed in triplicate.

Intestinal measurements

The previously reported criteria of Wang et al. (2017) were chosen in the present study to measure and evaluate the morphological characteristics of seabass intestine. Six parameters were measured with transverse sections for each of the 3 intestinal portions: the muscular layer (ML), submucosa layer (SML), lamina propria (LP), villus height (VH), width (VW), and goblet cell (GC) count. Ten measurements were recorded for each parameter to obtain the average value per treatment (6 parameters × 10 measurements × 3 intestinal portions × 4 dietary treatments).

Statistical analysis

Data are presented as means ± standard error (SE) (n = 3, unless otherwise stated). All data were subjected to a Shapiro-Wilk test (SAS Institute Inc., Cary, NC), and the results indicated a normal distribution (W = 0.90). To determine significant differences among dietary treatments, mean values were analysed by using one-way analysis of variance (ANOVA) followed by Duncan’s multiple range test, with a 0.05 probability level for significance. Before ANOVA, all data expressed as percentages were subjected to arcsine square root transformation.

Results

Growth and feeding performance

The acidifying effect of dietary SP had caused no negative effect on seabass appetite, and fish equally consumed the experimental diets without any noticeable behavioural or vigour change among dietary treatments. Feeding rate (%BW) was not significantly influenced by SP presence or level (P > 0.05) (Table 2). However, after treatment for 90 days, some growth performance criteria were found to be affected by SP presence and/or level (P < 0.05), with the SP3 diet resulting in the highest/best numerical values overall. A beneficial effect of the SP3 diet was observed for the FBW, WG, and daily WG (DWG, g/d), which showed significantly higher values at all tested SP concentrations than in the CTRL. A 34%, 19%, and 15.6% increase in WG was noted in SP3-, SP2-, and SP1-fed fish compared to CTRL-fed fish, which exhibited the lowest growth values among all fish groups. The SGR remained unaltered (P > 0.05) by the dietary treatments. Fish fed the SP3 diet exhibited significantly higher survival (97.5%) than those in all the other treatments, whilst the survival of fish fed the CTRL diet was the lowest (94%) but not significantly different from that of fish fed the other SP-treated diets.

Table 2 Growth and feed utilisation indices (mean ± SE) of European seabass (D. labrax) fry fed sodium propionate (SP)-supplemented diets for 90 days

The feed utilisation indices indicated significant positive effects (P < 0.05) of dietary SP on the FCR, the PER, and energy utilisation (EU, %), whereas the FR (% BW/d) remained unaffected (P > 0.05) among dietary groups. However, the FCR progressively improved/decreased with an increase in SP level, reaching the most significant value in the SP3-fed fish (1.20), followed by the SP2-fed fish (1.45), whilst the highest value was observed in the CTRL (1.82) fish group. Similarly, a gradual increase in the PER was observed with an increase in the dietary SP level, and the highest value was recorded in fish fed the SP3 diet, followed by those fed the SP2 diet, whereas those fed the CTRL or SP1 diet exhibited the lowest values. In addition, increasing levels of SP did not significantly influence (P > 0.05) the PPV, energy gain or energy retention, whereas the EU was significantly higher in both the SP3 and SP2 fish groups than in the CTRL and SP1 fish groups (Table 2).

Proximate composition of fish

None of the provided diets affected seabass whole-body composition, except for protein content, which exhibited a significant (P < 0.05) increase (16.13% or 15.0%, respectively) in SP3- or SP2-fed fish compared to CTRL fish (14.76%) (Table 3).

Table 3 Whole-body composition (mean ± SE, means adjusted for live body weight) of European seabass (D. labrax) fry fed sodium propionate (SP) containing diets for 90 days

Haematology and blood biochemistry

The SP-containing diets positively (P < 0.05) affected major blood constituents of seabass fry (Table 4). The haemoglobin content progressively increased with each increase in dietary SP level, reaching its highest value in SP3-fed fish, which was comparable (P > 0.05) to that of SP2- and SP1-fed fish but significantly lower than that of CTRL fish. A similar trend was also observed for haematocrit values. The total erythrocyte (RBC) count was highest in the SP1 and SP2 fish groups, followed by the SP3 group, whereas CTRL fish exhibited a significantly (P < 0.05) lower RBC count than fish in all the other dietary groups. Regarding erythrocyte characteristics, the MCV increased significantly in only SP2 fish, and the MCHC significantly increased in SP3 fish, whilst MCH was significantly higher in all SP-fed fish, particularly the SP3 and SP2 fish groups, than in CTRL-fed fish. The total WBC/leukocyte count was significantly higher with SP dietary inclusion, particularly in SP2- and SP3-fed fish, than in the CTRL and SP1 dietary groups. Both the lymphocyte and monocyte percentages were significantly higher in fish fed either the SP2 or SP3 diet than in those fed the CTRL or SP1 diet (Table 4). These data suggest that both SP2 and SP3 diets led to enhanced blood profiles in seabass fry over 90 days of feeding with SP-supplemented diets.

Table 4 Major blood constituents (mean ± SE) and serum immunity indicators of European seabass (D. labrax) fed sodium propionate (SP)–containing diets for 90 days

Immunological assays

Immunity indicators in fish serum, namely, the respiratory burst activity of leukocytes (NBT), phagocytic (PA), lysozyme (LA), myeloperoxidase (MPO) enzyme and bactericidal activities, and total immunoglobulin M (IgM), were all estimated at the end of the trial and are represented in Table 4 (bottom section). Fish fed the SP3 or SP2 diet displayed a significantly higher respiratory burst activity, phagocytic activity of leukocytes index, myeloperoxidase enzyme activity, and bactericidal activity than CTRL fish, which showed values relatively lower than but comparable (P > 0.05) to those of SP1-fish. However, the LA and IgM did not respond (P > 0.05) to dietary SP presence and level. In summary, both 0.2% and 0.3% dietary SP supplementation significantly increased the main measured immunity indicators compared to the CTRL (untreated) diet.

Intestinal microbiota

The microbial populations from the DI of seabass fry fed SP-containing diets were identical among the replicate samples of each treatment. Supplementation with SP significantly modified the bacterial community of the DI, causing an approximately 95%, 87%, and 44% reduction in the total bacterial count at the 0.3%, 0.2%, and 0.1% levels, respectively, compared with the CTRL diet, which showed the highest bacterial count among all treatments (Table 5). Vibrio spp. were non-existent (zero or negligible) in the DI of fish fed either the SP2 or SP3 diet but were significantly lower in SP1-fed fish than in CTRL-fed fish. Similarly, estimates of faecal coliform bacteria gradually decreased with each increase in SP level, reaching significance in SP2-fed fish and zero (an approximately 52% reduction) in SP3-fed fish compared to CTRL-fed fish. However, the beneficial acid-fermentative bacteria were significantly affected by neither SP presence nor SP level.

Table 5 Distal intestine microbioal load (mean ± SE) of European seabass (D. labrax) fed sodium propionate (SP)–containing diets for 90 days

Intestinal histology

Six parameters were measured in intestinal sections, namely, the thickness of the ML, SML, VH, and VW in the epithelium brush border of the lumen, GC count, and LP. The means of each parameter from each of the three segments of the seabass intestine (PI, MI, and DI) are given in Table 6. For most measurements, the majority of significant variations were detected in the DI portion. Both the ML and SML were significantly different among dietary treatments in only the DI. Fish fed the SP3 diet exhibited the greatest thickness (P < 0.05) of the ML, followed by SP2-fed fish, whereas SP1-fed fish showed a value comparable (P > 0.05) to that of CTRL-fed fish (Fig. 1a–d). The thickness of the SML was significantly higher in SP3-fed fish than in fish in all the other treatments, but diet had no appreciable effect on the SML in either the SP1 or SP2 fish group relative to the CTRL fish group (Fig. 2). Additionally, dietary SP significantly influenced the intestinal VH in the epithelium brush border of both the PI and DI. In the PI, the VH significantly and gradually increased in all SP-fed fish relative to that in CTRL-fed fish and peaked in the SP3-fed fish group. In the DI, only SP3-fed fish displayed a significant elevation in VH relative to fish in the other treatments or the CTRL. However, the VW gradually and progressively increased with each increase in dietary SP level in both the MI and DI compared to that of CTRL-fed fish. In the MI, the most significant VW values were observed in SP3- and SP2-fed fish, followed by SP1-fed fish. Similarly, in the DI, the VW was remarkably higher in SP3-fed fish than in CTRL-fed fish and other SP-fed fish groups. Therefore, the SP3 diet significantly improved the villus area (VH and VW) in the epithelium brush border of the DI compared to the CTRL diet (Fig. 2a–d).

Table 6 Measurements of some parameters (mean ± SE, n = 10) in different portions of the intestine of seabass (D. labrax) fed sodium propionate (SP)–containing diets for 90 days
Fig. 1
figure 1

ad Photo micrographs of TS in distal intestine of seabass fry fed sodium propionate (SP)–containing diets: a CTRL fish with the lowest thickness of muscular (ML) and submucosa (SML) layers; b SP1-fed fish; c SP2-fed fish; d SP3-fed fish with relatively thicker layers (H&E, × 40]

Fig. 2
figure 2

ad Photo micrographs of TS in distal intestine of seabass fry fed sodium propionate (SP)–containing diets, showing details of villus (V) structure: a, b fish fed CTRL and SP1 diets, showing enterocytes (E); goblet cells (GC, stars) some leucocytes infiltration (head arrows) from lamina propria (LP), c fish fed SP2 diet showing normal enterocytes (E) with basal nucleus; normal lamina propira (LP) with the lowest leucocytes infiltration, goblet cells (GC, stars); d fish fed SP3 diet with goblet cells (GC, stars); lamina propira (LP) and few leucocytes infiltration (head arrows). [H&E, × 100]

The secreting GC count was unaffected (P > 0.05) by diet in both the PI and MI, whereas in the DI, a remarkable increase in GC number (P < 0.05) was observed in all SP-fed fish, particularly SP2- and SP3-fed fish, relative to that in CTRL-fed fish. Moreover, a significant (P < 0.05) effect of SP level on the LP measure was observed in both the proximal and distal portions of the intestine. In the PI, the LP was increased in both SP2- and SP3-fed fish relative to that in CTRL-fed fish, whilst for SP1-fed fish, it remained unchanged (P > 0.05). In the MI, the dietary treatments resulted in similar LP measures. In contrast, in the DI, the LP was reduced in both SP2- and SP3-fed fish compared to that in either the CTRL fish or SP1-fed fish (Table 6).

Discussion

SP and calcium propionate have been found to have positive effects on the performance and health of some species of fish and shrimp (Hoseinifar et al., 2017; Ng and Koh, 2016). Overall, the present study supports the use of SP in seabass fry diets to enhance overall performance, nutrient utilisation, and general health status. Variation in the response of seabass to dietary SP was evident among the 3 tested doses and was more pronounced at the relatively high levels (0.3% and 0.2%). Whilst the medium (0.2%) and high (0.3%) doses of SP significantly enhanced the growth and survival of seabass fry and affected the gastrointestinal microbiota in this study, the lowest dose (0.1%) had a relatively weak or sometimes no effect. The highest SP dose (0.3%) had no negative effects on the FR (%BW/d) but enhanced both growth and feed efficiency (Table 2). Our findings confirm that of Hoseinifar et al. (2016), in which 0.25% dietary SP had beneficial effects on the growth performance of Caspian white fish (R. frisii kutum) fry.

The higher WG in seabass fed SP diets in the present research may be linked to SP is utilised in the gastrointestinal tract of seabass as an additional energy source (Lückstädt, 2008a, b), leading to an enhanced growth rate and better protein utilisation than those observed in fish not receiving the supplement. Moreover, the increased PER indicated that more dietary energy/protein was released by the use of SP. Our experiment yielded good growth similar to or greater than that previously reported for seabass of a similar size (Kousoulaki et al., 2015), reflecting the appropriateness of the diet formulation, rearing conditions and fish welfare.

The most important modes of action of acidifiers are their antimicrobial effect and stimulation and activation of digestive enzymes (Lückstädt, 2008a, b). Organic acids/salts might alter the availability and enhance the absorption of certain nutrients, such as amino acids, lipids, and phosphorus (Sarker et al., 2012; Morken et al., 2011). Our results indicated that SP has beneficial effects on seabass fry, leading to enhanced survival, growth, and disease resistance and a controlling effect on the gastrointestinal microbiota composition. These findings are consistent with those of prior studies that demonstrated improvement in these criteria upon dietary supplementation with propionic acid/salts for other fish species (Ringø, 1991; Hassaan et al., 2014; Safari et al., 2016; Reda et al., 2016; Hoseinifar et al., 2016) and shrimps (da Silva et al., 2016). However, the advantageous effect of SP on the FCR of seabass in the present study is in contrast to the lack of a significant effect on the FCR of Caspian white fish (Hoseinifar et al., 2016).

Fish fry relies on only their innate immune system whilst their adaptive immune system is still developing, making them susceptible to infectious diseases (Magnadottír, 2006). Again, the antimicrobial effect of SP was evident in the current study, which led to higher survival (97.5%) of 0.3% SP-fed seabass fry than of fry not receiving the supplement (94%). This effect may be attributed to the fact that dietary acidification by SP is an effective strategy for reducing the impacts of pathogens and improving disease resistance in seabass fry, suggesting an immunity-boosting effect. These findings are consistent with those of previous reports, which indicated that diet acidification is commonly practised to enhance disease resistance in aquaculture production (Menanteau-Ledouble et al., 2017).

The effects of dietary supplementation with organic acids/salts on the haemato-immunological parameters of aquatic animals are poorly studied, but the antimicrobial activity of these substances against a broad spectrum of pathogens such as bacteria has been demonstrated (Ringo et al., 2015), and SP is no exception. Acidifiers reduce the gut pH and provide nutrients to the host, changes that partly explain the reported beneficial effects of acidifiers in fish, such as improved growth, disease resistance, and immunity (Hoseinifar et al., 2017). In line with our findings, feeding 1% or 2% propionic acid to Nile tilapia (O. niloticus) and 0.25% SP to Caspian white fish (R. frisii kutum) significantly improved certain immunological indicators, including the serum bactericidal index, LA, and nitric oxide (Reda et al., 2016; Hoseinifar et al., 2016).

Investigating the effect of dietary components on the gut microbiota is important as the gastrointestinal tract (GIT) is thought to be one of the major routes of infection in fish. Very few studies have reported changes in the bacterial community in the GIT of seabass (Guerreiro et al., 2018; Sun et al., 2013; Carda-Dieguez et al., 2013) or a reduction in Vibrio in the intestine of other marine fish with the use of propionic acid or salts (Hoseinifar et al., 2017). However, the effects of organic acids/salts go beyond the modification of gut microflora, and other benefits, such as improved digestive enzyme activity, increased pancreatic secretion, enhanced development of the intestinal epithelium and intestinal barrier integrity, and better anti-inflammatory properties, have often been observed and identified as likely causes of enhanced performance when supplementing diets with some of these organic salts (Piñeiro et al., 2013). The positive changes in gut microbiota composition observed in our study indicated that the overall microbial community was positively modified to a large extent by dietary SP and contributed to the enhanced growth performance, immune status, and protein efficiency in seabass fed a 0.3% or 0.2% propionate diet. The observed modification in the intestinal microbial community likely developed due to propionate presence and/or level causing a decrease in the intestinal pH, which inhibits the growth of certain pathogenic bacteria (Ringo et al., 2015). Our results confirmed that SP possesses inhibitory potential against Vibrio spp., as suggested by Defoirdt et al. (2011), but the beneficial acid-fermentative bacteria did not respond positively to SP presence nor level (Cotter and Hill, 2003). The present research confirms previous reports that dietary sodium/calcium propionate can effectively enhance the gut health of seabass fry and disease resistance of tilapia (Hassaan et al., 2014), Caspian white fish (Hoseinifar et al., 2016) and shrimps (da silva et al., 2016).

Studies on the effects of dietary acidifiers on fish intestinal histomorphology are very limited. The results of the present research clearly show that SP has an impact on the morphological characteristics of three regions (PI, MI, and DI) of the seabass intestine, especially the distal portion. In general, the intestinal structure of seabass is in agreement with the features of intestinal layers previously reported by Bonaldo et al. (2008), Cerezuela et al. (2012), Rimoldi et al. (2016), and Abdel Mohsen et al. (2018). The present investigation revealed an increase in the thickness of both the ML and SML in the DI of fish fed the 0.3% SP diet relative to that in fish fed the non-supplemented diet, in contrast to the results of Rimoldi et al. (2016) for seabass (540 g) administered an acidified high soy protein diet with 0.2% sodium butyrate. These differences are probably due to the use of different acidifiers, fish sizes, and diet compositions. The epithelium brush border layer is the area where much of the absorption of nutrients occurs (Cerezuela et al., 2012). Therefore, the increase in LP and GC number observed in the present study may have been associated with increased nutrient absorption in seabass fry fed propionate diets. In aquatic animals, intestinal VH is regarded as a proxy for absorption ability (Cerezuela et al., 2012). Similarly, our findings showed that diets containing propionate caused an increase in VH in the PI and DI and VW in the DI, which revealed the trophic effects of propionate on the intestinal epithelium of seabass through an increase in the VH and crypt depth. This increase in villus area could be related to the number of absorptive cells, which would make these villi appear more or less bulky. Furthermore, it was recently reported that sodium butyrate improved the intestinal morphology of seabass fry by increasing the gut absorptive area in the lumen, microvillus density and height, and villus structural complexity (Abdel-Mohsen et al., 2018). In contrast, shortening of the primary and secondary intestinal mucosal folds is suggested to be a typical sign of intestinal inflammation (Rimoldi et al., 2016). Our findings are consistent with that of a previous report in which acidifiers (such as SP) stimulated gut secretions, which increased nutrient utilisation and protein synthesis and, ultimately, fish protein content (Freccia et al., 2014). Fish intestinal mucosa consists of a simple epithelium with abundant GCs and an LP containing infiltrated leucocytes and a continuous mucus layer. In our research, a comparison of GC numbers along the entire intestine of seabass fry revealed a higher count in the posterior portion (DI) than in the anterior portion (PI). GCs secrete high-molecular-weight glycoproteins called mucins (Forstner, 1978). The mucus layer keeps the epithelium moist, acts as a lubricant, traps microbes, and aids in the expulsion of microorganisms (Basset et al., 2003). Consequently, higher GC numbers also relate to increased protection and lubrication for faecal exclusion (Dai et al., 2007) when seabass are fed a 0.3% or 0.2% SP diet. To summarise, SP can stimulate digestive secretions, increase VH and villus density, and increase mucus production through an increase in the number of GCs.

Conclusions

Overall, several beneficial effects of including 0.3% (or sometimes 0.2%) SP in the diets of seabass fry were observed, such as an improvement in growth, the FCR, the PER, and EU, thereby improving survival and yield. Therefore, SP positively affected seabass fry performance and protein content and was very efficient for further improving health and immunity. Moreover, SP positively modified the gut microbiota as well as intestinal morphological characteristics, thereby promoting fish gut health and well-being. These results show for the first time the potential for SP to act as an antibiotic-free growth promoter for seabass fry, possibly leading to heightened protection against pathogens; hence, it can be considered a potential biocontrol agent in small-fish culture, being additionally safe for consumers and the environment.